Reply to WB Grant
Dear Sir:
We appreciate Grant's interest in our recent article on fish consumption and cancer risk (1) as well as his comments on the relation between fish consumption and Alzheimer disease. As Grant pointed out, several but not all cancers considered were inversely related to fish consumption (Figure 1) . The findings from the case-control studies conducted between 1983 and 1996 in northern Italy have been reproduced in recent case-control studies of cancers of the oral cavity, pharynx, and colorectum. These recent case-control studies were conducted in several regions of Italy and in the Swiss canton of Vaud and used a method similar to ours with a validated food-frequency questionnaire and questions recalling fish consumption (2) . For colorectal cancer, there was an inverse association with fish consumption in both the Italian study [odds ratio (OR) = 0.7 for the highest consumption level (3) ] and the Swiss study [OR = 0.9 (4)]. The inverse association was even more apparent for cancers of the oral cavity and pharynx, with an OR of 0.6 in the Italian study (5) and of 0.5 in the Swiss study (6) . There is, therefore, consistent evidence that fish consumption is a favorable indicator of cancer risk in these European populations.
With reference to the beneficial effect of fish consumption and nϪ3 fatty acid intakes on the development of Alzheimer disease, scarce epidemiologic information is available to date. Besides the ecologic analysis of Grant (7), a prospective cohort study from the Netherlands (8) showed that fish consumption is inversely related to incident dementia [relative risk (RR) = 0.4] and to Alzheimer disease (RR = 0.3). The results of other studies, however, are contradictory (9) . Although some reasonable biological mechanisms have been postulated, analytic epidemiologic studies aimed at addressing the role of fish consumption and other dietary factors (including food groups, nutrients, and micronutrients) would contribute to the investigation of the etiology of Alzheimer disease. 
Esteve Fernandez

Lactose intolerance-a confusing clinical diagnosis
We read with interest the paper published recently by Saltzman et al (1) concerning lactose intolerance. We consider it to be of great significance that > 40% of the subjects with self-reported lactose intolerance were, according to Saltzman et al (1) , lactose digesters.
In Finland, Ϸ17% of the population has hypolactasia (2) . The Finnish population is very much aware of lactose intolerance because of media coverage. Because milk and milk products are a large part of the Finnish diet, gastrointestinal problems are easily assumed to be caused by milk. Because many lactose maldigesters tolerate small amounts of lactose in their diet without experiencing any gastrointestinal symptoms (3), the concept of lactose intolerance becomes confusing.
Inspired by the interesting results of Saltzman et al (1), we combined our existing data from 4 different studies (4) (5) (6) (7) . Over the last few years, 68 subjects (mean age: 35 y; range: 18-65 y; 60 females and 10 males) participated in our blinded crossover FIGURE 1. Odds ratios (ORs) and 95% CIs for selected neoplasms among subjects in the highest versus the lowest category of fish consumption in Milan, Italy, 1983 Italy, -1996 trials set up to investigate the biochemical background of lactose intolerance (4-7). We used the 3 most commonly used lactose tolerance tests in these subjects. The diagnostic variables were as follows: increased blood glucose ≤ 1.1 mmol/L, increased excretion of breath hydrogen ≥ 20 ppm, and excreted urinary galactose ≤ 20 mg/3 h. Thirty-one subjects had previously received a diagnosis of lactose intolerance by a health care professional and the remaining 37 subjects were self-diagnosed. Using our gold standard of ≥ 2 of the 3 diagnostic variables being positive after ingestion of 50 g lactose in 250 or 300 mL water after an overnight fast (10 h), we found only half of the 31 subjects with a previous diagnosis of lactose tolerance and 40% of the 37 selfdiagnosed subjects to be lactose maldigesters (Figure 1) . Surprisingly, one-third of the 29 subjects diagnosed by us as lactose maldigesters had no clinically significant gastrointestinal symptoms for 3 h after ingesting 50 g lactose. At the same time, one-fourth of the 39 lactose digesters experienced clinically significant gastrointestinal symptoms after ingesting the same amount of lactose. However, the gastrointestinal symptoms differed between the lactose maldigesters and the digesters. Flatulence was the most severe symptom in the maldigesters (Ϸ40% of the individual maximum scores) and abdominal bloating was the most severe symptom in the symptomatic digesters (> 40% of the individual scores). In both of these groups, the severity of the other symptoms was roughly the same (Ϸ20%). Clearly, there is a danger that those lactose digesters who experienced symptoms could receive an incorrect diagnosis of lactose intolerance. Thus, it is essential that the diagnostic tests be conducted carefully.
It is obvious that secondary lactose intolerance due to epithelial damage (secondary hypolactasia) is common. Therefore, the diagnosis of lactose intolerance needs to be made with carefully controlled clinical lactose tolerance tests, preferably more than one. In cases in which values are borderline, a repeat test should be conducted, preferably with use of a different diagnostic method after a period of time. It is hoped that more studies concerning the problems related to the diagnosis of lactose intolerance, like that by Saltzman et al (1), will be carried out. (n = 2) (n = 7) (n = 9) (n = 7) (n = 7) (n = 4) (n = 19) FIGURE 1. Distribution of subjects with a previous diagnosis of lactose maldigestion and those self-diagnosed as lactose intolerant according to symptoms and laboratory findings after ingestion of 50 g lactose in a blinded crossover study design in our laboratory.
Katri Peuhkuri Heikki Vapaatalo
Institute of Biomedicine
* Positive findings for ≥ 2 of the 3 variables (increase in blood glucose, breath hydrogen, or urinary galactose excretion). 
Programming not metabolic imprinting
The recent review by Waterland and Garza (1) builds usefully on the list of programming (or imprinting) mechanisms that I proposed several years ago (2-4) and that are cited in their article. It is pleasing to see these ideas developed further. We pioneered the experimental approach to testing the influence of early nutrition as a complex environmental programming trigger in humans. This has involved the study of thousands of infants and children over the past 2 decades to whom their early diets have been assigned randomly. In some of the original studies we undertook, subjects have now been followed prospectively into late childhood and early adult life. Such studies (recently summarized in reference 4) provide some of the first experimental, as opposed to observational, data on the sensitivity of humans to nutritional programming. These findings, together with many recent observational studies in the field, certainly justify investment now in the study of the fundamental biological mechanisms involved.
However, there is one point on which I would disagree with the authors-terminology. Originally, I used the term programming in this context in the early 1980s (5), and later defined it more formally (1) to denote the concept that a stimulus or insult operating at a critical or sensitive period of development could result in a long-standing or life-long effect on the structure or function of the organism. The important underlying idea in this definition is that the programming event can only occur during a specific window of sensitivity.
Waterland and Garza propose changing the term programming to metabolic imprinting. Although I would be happy to see any useful advance, it seems to me that the term metabolic imprinting is a less useful and more biologically impoverished one. The reason for this is that the fundamental idea of programming encompasses such a broad range of biological events. Consider, for instance, the evidence that visual inputs must be received by the eye during a critical period in order for the visual pathway to develop normally (hence, squint amblyopia). Although in the end everything relates in some way to metabolism, in this example, the term metabolic imprinting is not descriptive because neither the stimulus (light and visual inputs) nor the effects (development of the visual pathway) are obviously metabolic in nature. Indeed Lorenz' use of imprinting (quoted by Waterland and Garza in support of their proposed terminology) refers to such phenomena as the tendency of newborn chicks to follow the first moving object (occasionally a human; 6)-again not an obviously metabolic event. Lorenz in fact used the term imprinting not metabolic imprinting. I agree that imprinting could be substituted for programming, but this would be confusing because the term has now taken on another biological meaning (imprinted genes). In view of this, the term metabolic imprinting should be rejected as being conceptually too narrow, possibly confusing, and not a useful advancement on the term programming, which is wellestablished in the current scientific literature on the subject. 
Alan Lucas
MRC
